Effects of renin-angiotensin system inhibitors in cancer patients: a systematic review and meta-analysis of randomized controlled trials
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Hypertension research : official journal of the Japanese Society of Hypertension
- Publicado em
- 9 out 2025
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effects of renin-angiotensin system inhibitors in cancer patients: a systematic review and meta-analysis of randomized controlled trials
Satoshi Ishii, Yohei Hanajima, Naohiro Komura, Shintaro Minegishi, Yoshinori Okazaki, Akira Horigome, Kyoko Hattori, Masanari Asai, Takumi Tokoro, Nobuyuki Horita et al.
Descritores MeSH
- Renin-Angiotensin System
- Neoplasms
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Antineoplastic Agents
- Cardiotoxicity
- Humans
- Quality of Life
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis
- Potential role of Aliskiren in cancer modulation compared to other Renin-Angiotensin inhibitors: an in-depth review
- Prevention of anthracycline and trastuzumab-induced decline in left ventricular ejection fraction with angiotensin-converting enzyme inhibitors or angiotensin receptor blocker: a narrative systematic review of randomised controlled trials
- Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction